[Brain functional imaging in Alzheimer's disease]
- PMID: 20061230
- DOI: 10.1684/pnv.2009.0193
[Brain functional imaging in Alzheimer's disease]
Abstract
Alzheimer's disease is nowadays the leading cause of dementia. It affects more than a third of people over 85 years old. The gold standard diagnostic proof is currently based upon pathology examination. It seems rather crucial to find methodologies that make an early and accurate in vivo diagnosis so as to offer the patient the most suitable treatment. We hereby go over several available neuro-imaging techniques used in nuclear medicine that increase the diagnostic accuracy of Alzheimer's disease.
Similar articles
-
Differentiation of dementia with Lewy bodies from Alzheimer's disease using Mini-Mental State Examination and brain perfusion SPECT.J Neurol Sci. 2006 Dec 1;250(1-2):97-102. doi: 10.1016/j.jns.2006.07.007. Epub 2006 Sep 26. J Neurol Sci. 2006. PMID: 17005204
-
[Imaging diagnosis of Alzheimer's disease].Rofo. 2012 Dec;184(12):1079-82. doi: 10.1055/s-0032-1319030. Epub 2012 Dec 4. Rofo. 2012. PMID: 23212812 Review. German. No abstract available.
-
Differentiation of early-stage Alzheimer's disease from other types of dementia using brain perfusion single photon emission computed tomography with easy Z-score imaging system analysis.Dement Geriatr Cogn Disord. 2008;26(6):547-55. doi: 10.1159/000180280. Epub 2008 Dec 10. Dement Geriatr Cogn Disord. 2008. PMID: 19066428
-
Neuroimaging as a diagnostic tool in dementia with Lewy bodies.Dement Geriatr Cogn Disord. 2004;17 Suppl 1:25-31. doi: 10.1159/000074679. Dement Geriatr Cogn Disord. 2004. PMID: 14676466 Review.
-
Predicting the accuracy of a diagnosis of Alzheimer's disease with 99mTc HMPAO single photon emission computed tomography.Psychiatry Res. 2004 Jul 30;131(2):157-68. doi: 10.1016/j.pscychresns.2003.11.001. Psychiatry Res. 2004. PMID: 15313522
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical